Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study
Zachariah DeFilipp, Richard Ancheta, Ying Liu, Zhen Huan Hu, Robert Peter Gale, David Snyder, Harry C. Schouten, Matt Kalaycio, Gerhard C. Hildebrandt, Celalettin Ustun, Andrew Daly, Siddhartha Ganguly, Yoshihiro Inamoto, Mark Litzow, Jeffrey Szer, Mary Lynn Savoie, Nasheed Hossain, Mohamed A. Kharfan-Dabaja, Mehdi Hamadani, Ran ReshefAshish Bajel, Kirk R. Schultz, Shahinaz Gadalla, Aaron Gerds, Jane Liesveld, Mark B. Juckett, Rammurti Kamble, Shahrukh Hashmi, Hisham Abdel-Azim, Melhem Solh, Ulrike Bacher, Hillard Lazarus, Richard Olsson, Jean Yves Cahn, Michael R. Grunwald, Bipin N. Savani, Jean Yared, Jacob M. Rowe, Jan Cerny, Naeem A. Chaudhri, Mahmoud Aljurf, Amer Beitinjaneh, Sachiko Seo, Taiga Nishihori, Jack W. Hsu, Muthalagu Ramanathan, Edwin Alyea, Uday Popat, Ronald Sobecks, Wael Saber
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study'. Together they form a unique fingerprint.